1.
Weinbergerová B, Čerňan M, Kabut T, Semerád L, Podstavková N, Szotkowski T, Ježíšková I, Mayer J. Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for <i>FLT3</i&gt;- mutated acute myeloid leukemia patients – Czech center experience. haematol [Internet]. 2023Oct.1 [cited 2024Jul.22];108(10):2826-9. Available from: https://haematologica.org/article/view/haematol.2022.282263